NCT01400698 Clinical Trial Information | SourceSolution's Biotech, Pharma, CMO, CRO Directory

Saizen in Intra-uterine Growth Retardation


Sponsors: Merck KGaA Merck Serono S.A., Geneva	Phases: Phase III
Indications	Acronym:
Children Born With Serious Intra-uterine Growth Retardation
Age Groups: Child Adult Senior	Gender: Both
Names: Drug: Saizen Drug: Saizen	Enrollment: 91

Additional information about NCT01400698.